Sign in
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of beta-blockade
Journal article   Peer reviewed

Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of beta-blockade

Gareth J. Padfield, Leenah AlAhmari, Krystien V. V. Lieve, Tasneem AlAhmari, Thomas M. Roston, Arthur A. Wilde, Andrew D. Krahn and Shubhayan Sanatani
Heart rhythm, Vol.13(2), pp.609-613
01/02/2016
PMID: 26416620

Abstract

Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Life Sciences & Biomedicine Science & Technology

Details